ACAAI 2024 Insights: Results From a Phase 2, Randomized, Placebo-Controlled Trial of CRISPR-Based Therapy NTLA-2002 for Hereditary Angioedema

46 views
November 21, 2024
Comments 0
Login to view comments. Click here to Login